MOS
LGND icon

MGO One Seven’s Ligand Pharmaceuticals LGND Stock Holding History

MGO One Seven’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$4K Sell
38
-2,057
-98% -$203K ﹤0.01% 1374
2017
Q4 		$179K Buy
+2,095
New +$182K 0.08% 283

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

MGO One Seven's LGND Position: Q1 2018 in Review

MGO One Seven reduced its Ligand Pharmaceuticals (LGND) stake by 98% in Q1 2018, selling an estimated $203K and leaving 38 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

MGO One Seven first reported a position in LGND in Q4 2017 and has held it in 2 quarters since. The position peaked at $179K in Q4 2017. 326 funds tracked by Wall St. Rank hold LGND as of Q1 2018.

  • MGO One Seven held 38 shares of Ligand Pharmaceuticals worth $4K as of Q1 2018.
  • MGO One Seven sold 2,057 Ligand Pharmaceuticals shares in Q1 2018, an estimated $203K.
  • Ligand Pharmaceuticals made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1374 holding.
  • MGO One Seven first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 2 quarters since.
  • MGO One Seven's Ligand Pharmaceuticals position peaked at $179K in Q4 2017.
  • 326 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.